2-Chloro-4,5-dimethoxypyrimidine

Catalog No.: 
ACXSQN376
CAS No.: 
1333240-17-7
Molecular Formula: 
C6H7ClN2O2
Molecular Weight: 
174.59
2-Chloro-4,5-dimethoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$129.00In stockInquiry
5g95%$507.00In stockInquiry
10g95%$812.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-4,5-dimethoxypyrimidine
IUPAC Name2-chloro-4,5-dimethoxypyrimidine
MDL No.MFCD21098377
Molecular FormulaC6H7ClN2O2
Molecular Weight174.59
SMILESCOC1=CN=C(Cl)N=C1OC
InChI KeyKIIOOCFFMSRIHK-UHFFFAOYSA-N
Synonym2-Chloro-4,5-diMethoxy-pyriMidine;Pyrimidine, 2-chloro-4,5-dimethoxy-
CAS No.1333240-17-7
PubChem CID66569546

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXSQN376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACZAHU369 route compound structure diagram
    ACZAHU36919646-07-2In Stock
  4. Then
  5. ACXSQN376 route product structure diagram
    ACXSQN3761333240-17-7In Stock
Inquiry

2. ACXSQN376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZAHU369 route compound structure diagram
    ACZAHU36919646-07-2In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACXSQN376 route product structure diagram
    ACXSQN3761333240-17-7In Stock
Inquiry

3. ACXSQN376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXSQN376 route product structure diagram
    ACXSQN3761333240-17-7In Stock
Inquiry

Comments (0)